SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

01 Nov 2021 Evaluate
The sales is pegged at Rs. 501.05 millions for the September 2021 quarter. The mentioned figure indicates a decline of about -30.57% as against Rs. 721.70 millions during the year-ago period.The Net Profit of the company slipped to Rs. 42.87 millions from Rs. 97.15 millions, a decline of -55.87% on QoQ basis.A decline of 58.29 millions was observed in the OP in the quarter ended September 2021 from 171.97 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 501.05 721.70 -30.57 967.62 1275.17 -24.12 2654.57 2273.33 16.77
Other Income 104.11 61.01 70.64 161.74 83.76 93.10 199.66 145.61 37.12
PBIDT 58.29 171.97 -66.10 74.31 281.37 -73.59 552.56 367.98 50.16
Interest 2.79 7.27 -61.62 4.46 18.28 -75.60 26.80 50.35 -46.77
PBDT 55.50 138.22 -59.85 69.85 236.61 -70.48 500.15 317.63 57.46
Depreciation 25.40 21.64 17.38 48.48 43.28 12.01 91.28 89.50 1.99
PBT 30.10 116.58 -74.18 21.37 193.33 -88.95 408.87 228.13 79.23
TAX -12.77 19.43 -165.72 -15.41 35.88 -142.95 87.74 14.72 496.06
Deferred Tax 6.13 11.79 -48.01 5.07 10.69 -52.57 26.89 -17.11 -257.16
PAT 42.87 97.15 -55.87 36.78 157.45 -76.64 321.13 213.41 50.48
Equity 496.74 496.74 0.00 496.74 496.74 0.00 496.74 496.74 0.00
PBIDTM(%) 11.63 23.83 -51.18 7.68 22.07 -65.20 20.82 16.19 28.59

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×